About this trial

To evaluate the capability to monitor LBB success criteria with the use of a Smart ECG system (ECG monitor, 12 leads ECG cable, ECG viewer software ) during a cardiac device implantation involving the placement of a pacing lead in interventricular septum area

Eligibility criteria

Qualifiers

Subject with indication for LBBAP using an Electrophysiology ECG monitoring system (EP System) as part of pacemaker or CRT-P or CRT-D implant procedure (de novo implant, device revision or upgrade including LOT-CRT)

Subject signed and dated the ICF

Disqualifiers

Incapacitated subject or under guardianship

inability to understand the purpose of the study

Minor subjects

Non menopausal women

Trial design

Treatments tested in this trial

  • LBBAP implant

Treatment groups

55 Participants
are divided into 1 treatment group

Locations

4
CHU de Besançon25030, BesançonFrance, France
Clermont Ferrand63003, Clermont-FerrandFrance, France
CHU Grenoble Alpes38043, GrenobleFrance, France
Clinique du Millénaire34000, MontpellierFrance, France

Sponsors and collaborators

MicroPort CRM

Lead sponsor